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Objectives. The aim of this study was to compare the cardio-
protective effects of preconditioning in hearts from streptozotocin-
induced diabetic rats with its effects in normal rat hearts.
Background. The protective effect of ischemic preconditioning
against myocardial ischemia may come from improved energy
balance. However, it is not known whether preconditioning can
also afford protection to diabetic hearts.
Methods. Isolated perfused rat hearts were either subjected
(preconditioned group) or not subjected (control group) to pre-
conditioning before 30 min of sustained ischemia and 30 min of
reperfusion. Preconditioning was achieved with two cycles of 5 min
of ischemia followed by 5 min of reperfusion.
Results. In the preconditioned groups of both normal and
diabetic rats, left ventricular developed pressure, high energy
phosphates, mitochondrial adenosine triphosphatase and adenine
nucleotide translocase activities were significantly preserved after
ischemia-reperfusion; cumulative creatine kinase release was
smaller during reperfusion; and myocardial lactate content was
significantly lower after sustained ischemia. However, cumulative
creatine kinase release was less in the preconditioned group of
diabetic rats than in the preconditioned group of normal rats.
Under ischemic conditions, more glycolytic metabolites were
produced in the diabetic rats (control group) than in the normal
rats, and preconditioning inhibited these metabolic changes to a
similar extent in both groups.
Conclusions. The present study demonstrates that in both
normal and diabetic rats, preservation of mitochondrial oxidative
phosphorylation and inhibition of glycolysis during ischemia can
contribute to preconditioning-induced cardioprotection. Further-
more, our data suggest that diabetic myocardium may benefit
more from preconditioning than normal myocardium, possibly as
a result of the reduced production of glycolytic metabolites during
sustained ischemia and the concomitant attenuation of intracel-
lular acidosis.
(J Am Coll Cardiol 1998;31:707–15)
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A brief ischemic insult followed by reperfusion renders the
heart more resistant to myocardial infarction from a subse-
quent ischemic insult. Since the initial description by Murry et
al. (1), the beneficial effects of ischemic preconditioning have
been observed in dogs (1,2), rabbits (3), pigs (4) and rats (5).
Recently, evidence was also presented for preconditioning in
the human myocardium, thereby emphasizing the potential
clinical significance of its cardioprotective effects (6). These
protective effects may involve several receptor-mediated mech-
anisms triggered by adenosine (7), catecholamines (8) and
bradykinin (9), as well as signal transduction through Gi
proteins or protein kinase C (10). The effector site of this
cardioprotection has not been clearly elucidated. However,
one of the most likely mechanisms may be an alteration in
myocardial energy metabolism.
Diabetes mellitus is a disorder of carbohydrate, lipid and
protein metabolism that affects many organs. In addition to
contractile abnormalities, this disease causes disturbances in
the function of cardiac subcellular organelles, including the
sarcolemma, sarcoplasmic reticulum and mitochondria (11). In
particular, diabetes is associated with several abnormalities in
energy metabolism (12). In view of the well established car-
dioprotective effects of ischemic preconditioning, it is of inter-
est to determine whether preconditioning can also afford
similar cardioprotection in diabetic hearts. In the present
study, we therefore examined the cardioprotective effects of
ischemic preconditioning on myocardial contractile function,
high energy phosphate (HEP) levels and mitochondrial en-
zyme function in streptozotocin-induced diabetic rats and
compared them with those in age-matched normal rats. We
also measured myocardial glycogen and lactate content to
evaluate the effect of anaerobic glycolysis on energy produc-
tion and myocardial damage.
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Methods
Animal preparation. Male Sprague-Dawley rats weighing
140 to 160 g were made diabetic by a single intraperitoneal
injection of streptozotocin (70 mg/kg body weight), which was
dissolved in citrate buffer, pH 4.5. Diabetic animals were
maintained on normal chow throughout the experimental
period. Four weeks after streptozotocin injection, diabetic rat
hearts were used as the diabetic group characterized in Table
1 (13). Age-matched normal male Sprague-Dawley rats were
used as a control group. The isolated heart preparation was
described previously (14). Briefly, rats were anesthetized with
intraperitoneal sodium pentobarbital (60 mg/kg) and hepa-
rinized. The hearts were excised rapidly and retrogradely
perfused through the aorta at a constant perfusion pressure of
80 mm Hg with Krebs-Henseleit buffer, consisting of 118
mmol/liter NaCl, 4.7 mmol/liter KCl, 1.2 mmol/liter MgSO4,
1.2 mmol/liter KH2PO4, 1.8 mmol/liter CaCl2, 25 mmol/liter
NaHCO3 and 11 mmol/liter glucose, at pH 7.4, oxygenated
with 95% oxygen and 5% carbon dioxide at 37°C. The atria
were removed and the hearts were paced at 270 beats/min. A
water-filled latex balloon inserted into the left ventricle was
used to measure left ventricular developed pressure (LVDP).
The left ventricular end-diastolic pressure was adjusted to
7 mm Hg during the initial equilibration.
Experimental design. All hearts were equilibrated for
20 min, subjected to 30 min of global normothermic (37°C)
ischemia by clamping the aortic line and then reperfused for
30 min. The hearts were divided into four groups: 1) normal
control group; 2) normal preconditioned group; 3) diabetic
control group; and 4) diabetic preconditioned group. In the
preconditioned group, preconditioning was achieved with two
cycles of 5 min of global ischemia followed by 5 min of
reperfusion before 30 min of sustained ischemia (14).
Creatine kinase release. Creatine kinase (CK) activity in
the coronary effluent was measured after equilibration and
preconditioning, as well as after 5 min, 10 min, 20 min and
30 min of reperfusion in each group. In addition, coronary
effluent during the 30 min of reperfusion was pooled and
cumulative CK release was determined for an estimation of
myocardial damage. Creatine kinase activity was assayed spec-
trophotometrically at 37°C according to Rosalki’s procedure
(14).
Measurement of adenine nucleotides, creatine phosphate
and creatine. Hearts were freeze-clamped with Wollenberger
tongs, prechilled in liquid nitrogen, after equilibration (base-
line), 30 min of ischemia or 30 min of reperfusion. The hearts
were kept in liquid nitrogen and then lyophilized overnight.
Forty-sixty milligrams of lyophilized tissue was homogenized in
0.6 N ice-cold perchloric acid and centrifuged at 2,000 rpm for
10 min at 4°C. The supernatants were neutralized with KOH to
pH 5.0 to 7.0. After 10 min, the extracts were centrifuged to
remove the KClO4, and the supernatants were used for the
assays. Creatine, creatine phosphate (CP), adenosine triphos-
phate (ATP), adenosine diphosphate (ADP), and adenosine
monophosphate (AMP) were measured by high performance
liquid chromatography (LC-9A liquid chromatograph, Shi-
madzu, Kyoto, Japan) with a column of STR ODS-M (Shi-
madzu) and are presented as mmol/g dry weight (14). Energy
charge was calculated from the formula (ATP 1 0.5 3
ADP)/(ATP 1 ADP 1 AMP).
Glycogen content. Myocardial glycogen content was mea-
sured enzymatically, according to the methods reported by
Brodal and Gehrken (15), with some modifications. Briefly,
10 mg of lyophilized heart tissue, which was prepared for
adenine nucleotide assay after equilibration (baseline) and
30 min of ischemia, was dissolved in 500 ml of 5.4 N KOH at
100°C for 20 min. The sample was neutralized with HCl to pH
7.0, and 100 ml of the sample was incubated with 80 ml of
50 mmol/liter acetate buffer (pH 4.6) and 20 ml of 2 IU/liter
amyloglucosidase at 37°C for 60 min. The glycogen content of
the sample was estimated by measuring the glucose concentra-
tion in the reaction mixture.
Lactate production. Myocardial lactate content was mea-
sured enzymatically using the Detaminer LA kit (Kyowa
Medics Co. Ltd., Tokyo, Japan). Aliquots of the supernatant
prepared for the adenine nucleotides assay (see above descrip-
tion) were added to a phosphate-buffered reaction mix con-
taining 0.9 mmol/liter N-ethyl-N-(3-methylphenyl)-N9-
acetylethylenediamine, 0.7 IU/ml lactate oxidase, 3.4 IU/ml
peroxidase and 0.4 mmol/liter 4-aminoantipyrine, at pH 6.4.
The lactate content was determined spectrophotometrically at
37°C by measuring the quinone content at 555 nm.
Mitochondrial isolation. Heart mitochondria were isolated
from hearts different from those used for the adenine nucleo-
tides assay, 20 min after equilibration or 30 min after ischemia-
reperfusion. The isolation method was similar to that reported
by Sordahl and Stewart (16), with some modification. At the
Abbreviations and Acronyms
ADP 5 adenosine diphosphate
AMP 5 adenosine monophosphate
ANOVA 5 analysis of variance
ATP 5 adenosine triphosphate
CK 5 creatine kinase
CP 5 creatine phosphate
HEP 5 high energy phosphate
LVDP 5 left ventricular developed pressure
NADH 5 reduced form of nicotinamide adenine dinucleotide





Body weight (g) 280 6 8.9 197 6 9.8*
Heart weight (g) 1.02 6 0.05 0.75 6 0.04*
Heart weight/body weight (mg/g) 3.71 6 0.28 3.86 6 0.24
Plasma glucose (mg/dl) 106 6 2.5 449 6 9.0*
*p , 0.001 compared with group of normal rats (n 5 12). Data are presented
as mean value 6 SEM.
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end of the experimental protocol, the heart was immediately
immersed in ice-cold phosphate-buffered saline. The ventricu-
lar myocardium was isolated, rinsed in ice-cold potassium
phosphate buffer consisting of 25 mmol/liter K2HPO4,
25 mmol/liter KH2PO4 and 1 mmol/liter EDTA, at pH 7.2, and
minced into very small pieces with scissors in 1.6 ml of
potassium-phosphate buffer containing 0.5 mmol/liter phenyl-
methanesulfonyl fluoride. The minced heart tissue was homog-
enized with a Polytron PT 10-35 tissue processor (Kinematica
Instrument) three times at a setting of 7 for 10 s, and the
homogenate was centrifuged at 27,000g for 10 min. The
supernatant was discarded and the pellet was suspended in
isolation medium (5% wt/vol) consisting of 0.18 mol/liter KCl,
5 mmol/liter Tris-HCl and 10 mmol/liter EGTA, at pH 7.2,
using a Teflon-glass homogenizer. The suspension was centri-
fuged at 1,000g for 10 min, and the supernatant was centri-
fuged at 12,000g for 10 min. The mitochondrial pellet was
washed once and resuspended in a 550-ml low salt medium
consisting of 20 mmol/liter HEPES, 1.0 mmol/liter MgCl2 and
2.0 mmol/liter EGTA, at pH 7.0. The protein concentration in
the mitochondrial suspension was determined by the Lowry
method (17).
Measurement of mitochondrial enzyme activity. The mito-
chondrial NADH cytochrome c oxidoreductase activity was
assayed spectrophotometrically at 30°C by measuring the ini-
tial rate of cytochrome c reduction at 550 nm in the presence
and absence of rotenone (15 mmol/liter) (18). Briefly, the
mitochondria in the low salt medium were sonicated twice for
5 s using an ultrasonic disrupter (model UR200P, Tomy Seiko
Co. Ltd., Tokyo, Japan). Aliquots of the sonicated mito-
chondria were added to 1 ml of a reaction buffer contain-
ing 0.1 mmol/liter cytochrome c, 0.3 mmol/liter KCN and
50 mmol/liter KH2PO4, at pH 7.5.
The mitochondrial ATPase activity was measured spectro-
photometrically by coupling the reaction to a pyruvate kinase
and lactate dehydrogenase system, according to the method of
Lowe (19). Briefly, aliquots of the sonicated mitochondria
were added to 1 ml of a reaction buffer containing 5 mmol/liter
phosphoenol pyruvate, 50 mg pyruvate kinase, 50 mg lactate
dehydrogenase, 25 mmol/liter Tris/H2SO4, 5 mmol/liter
MgSO4, 0.35 mmol/liter NADH and 2.5 mmol/liter ATP, at pH
8.0. Mitochondrial ATPase activity was determined at 30°C by
monitoring the decline of NADH oxidation at 340 nm in the
presence and absence of oligomycin (10 ng/ml).
A modified procedure of Duan and Karmazyn was used for
the measurement of adenine nucleotide translocase (20).
[14C]Adenosine disphosphate (50 nmol, specific activity 57.1
mCi/mmol, New England Nuclear Corp.) was added to a
reaction buffer consisting of 110 mmol/liter KCl, 1 mmol/liter
EDTA and 20 mmol/liter Tris-HCl, at pH 7.4, and 500 mg
mitochondrial protein. The reaction was carried out at 0°C and
stopped after 60 s by the addition of 0.1 mmol atractyloside.
The reaction mixture was centrifuged at 25,000g for 10 min and
the supernatant was discarded. The pellet was washed twice
with ice-cold reaction buffer and then dissolved in 500 ml of
0.012 N NaOH, 1.2% mercaptoethanol and 12% sodium
dodecylsulfate, by incubating at 50°C for 30 min. After addition
of Clearsol-I (Nacalai Tesque Co. Ltd., Kyoto, Japan), the
radioactivity was determined in a liquid scintillation counter
(Packard TRI-CARB 460, Packard Co. Ltd.). Adenine nucle-
otide translocase activity was measured as atractyloside-
sensitive ADP uptake per milligram of mitochondrial protein,
according to the method reported previously (21).
Statistical analysis. The data in Figures 1 and 2 were
analyzed by two-way analysis of variance (ANOVA), and the
data at each time point were analyzed by one-way ANOVA
and Tukey’s multiple comparison. The data in Figures 3, 4 and
5 and Table 2 were also analyzed by one-way ANOVA and
Tukey’s multiple comparison, and the data in Table 1 were
analyzed by the Wilcoxon two-sample test. Data are presented
as the mean value 6 SE, and a p value ,0.05 was considered
to be statistically significant.
Results
Experimental rats. The normal and diabetic rats used in
this study are compared in Table 1. Both body weight and heart
weight in the diabetic rats were significantly lower than those
weights in normal rats. Plasma glucose in diabetic rats was
routinely .400 mg/dl.
Myocardial function. The changes in cardiac performance
of control and preconditioned hearts from normal or diabetic
rats are illustrated in Figure 1. There was no significant
difference in initial LVDP between the control and precondi-
tioned groups in either normal or diabetic rats, but LVDP in
the diabetic rats was smaller than that in the normal rats (p ,
0.01). In the control hearts of either the normal or diabetic
rats, LVDP was markedly depressed after 30 min of sustained
ischemia and showed little recovery during 30 min of reperfu-
sion. In contrast, LVDP in the preconditioned hearts from
both groups showed significantly better recovery than that in
the control groups, although LVDP in the normal and diabetic
rats was reduced to 67% and 63% of the initial value after two
cycles of 5 min of ischemia followed by 5 min of reperfusion,
respectively.
Release of CK. The time-dependent changes in CK activity
in the coronary effluent, as well as the cumulative CK release,
during 30 min of reperfusion in the control and preconditioned
groups are illustrated in Figure 2. There was no significant
increase in CK release immediately after ischemic precondi-
tioning in either the normal or diabetic group. However, a
significant increase was observed in both groups on reperfu-
sion, with maximal CK activity detected at 5 to 10 min of
reperfusion, followed by a gradual decline. There was a
significantly greater cumulative release of CK from the control
groups than from the preconditioned groups. It is noteworthy
that cumulative CK release was significantly smaller in the
preconditioned group of diabetic rats than in the normal rats
(p , 0.05), although there was no significant difference be-
tween the control groups of normal and diabetic rats.
Adenine nucleotides, CP, creatine and energy charge. Ta-
ble 2 shows the absolute values of adenine nucleotides, CP,
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creatine and energy charge. In both normal and diabetic rats,
the ATP content decreased only slightly after ischemic precon-
ditioning, but was markedly lowered in both the control and
preconditioned groups after 30 min of ischemia. However,
after 30 min of reperfusion, ATP was significantly higher in the
preconditioned groups than in the control groups.
The time-dependent change in the ADP content was similar
to that of ATP in both the control and preconditioned groups
of either normal or diabetic rats. The ADP content declined
after sustained ischemia and recovered after reperfusion.
Thirty minutes of ischemia markedly increased the AMP level
by 17.8- and 8.9-fold in the control and preconditioned groups
of normal rats, and 10.4- and 6.4-fold in those of diabetic rats,
respectively. After reperfusion, AMP was depleted in both
groups. The sharp decline in the total adenine nucleotide pool
observed in the reperfused control groups was greatly attenu-
ated by preconditioning (Table 2).
Creatine phosphate was markedly decreased after 30 min of
sustained ischemia in both control and preconditioned groups
of either normal or diabetic rats. However, after reperfusion,
CP in the preconditioned hearts was significantly higher than
that in the control hearts. Immediately after preconditioning,
the CP content was greater than preischemic values in both
normal (123.4 6 1.5%) and diabetic (117.1 6 3.7%) rats.
Creatine content increased during sustained ischemia and
subsequently decreased during reperfusion in both groups.
The energy charge decreased after ischemia and recovered
significantly during reperfusion in both the control and pre-
conditioned groups of either normal or diabetic rats. However,
the energy charge was better preserved in the preconditioned
groups after 30 min of reperfusion, as shown in Table 2.
Myocardial glycogen content. The glycogen content at
baseline, immediately after preconditioning and 30 min after
sustained ischemia in both normal and diabetic rats is shown in
Figure 3. The preischemic glycogen content in diabetic hearts
was significantly greater than that in normal hearts (3.13 6
0.30 [normal] vs. 5.50 6 0.27 [diabetic] mg/g wet weight, p ,
0.001). The glycogen content was significantly reduced imme-
diately after preconditioning and was further decreased 30 min
after sustained ischemia in the preconditioned group of either
normal or diabetic rats. The glycogen content was also mark-
edly reduced 30 min after sustained ischemia in the control
group of either normal or diabetic rats.
Myocardial lactate content. In both normal and diabetic
rats, the myocardial lactate content was significantly lower in
the preconditioned groups after 30 min of sustained ischemia,
as shown in Figure 4. There was no significant difference in the
lactate content before sustained ischemia among the four
groups (data not shown).
Mitochondrial enzyme activities. The initial preischemic
activity of rotenone-sensitive NADH cytochrome c oxi-
doreductase, oligomycin-sensitive ATPase and adenine nucle-
otide translocase tended to be lower in diabetic than in normal
rats (NADH cytochrome c oxidoreductase: 0.44 6 0.03 [nor-
mal] vs. 0.35 6 0.04 [diabetic] mmol cytochrome c reduced/min
per mg protein; ATPase: 2.18 6 0.06 [normal] vs. 1.04 6 0.04
[diabetic] mmol NADH oxidized/min per mg protein, p , 0.05;
adenine nucleotide translocase: 0.95 6 0.06 [normal] vs. 0.86 6
0.11 [diabetic] nmol ADP uptake/min per mg protein). Figure
5 shows the percent decline in the activity of these enzymes
after sustained ischemia followed by reperfusion. At the end of
the 30 min of reperfusion, NADH cytochrome c oxidoreduc-
tase activity was decreased to a similar extent in the control
and preconditioned groups of both normal and diabetic rats
when compared with preischemic values. In contrast, ATPase
activity was not significantly decreased after reperfusion in the
preconditioned group in either the normal or diabetic rats, but
was significantly lower in control hearts of both groups.
Adenine nucleotide translocase activity declined after reperfu-
sion in both the control and preconditioned groups, but the
activity in the preconditioned hearts was significantly higher
than that in control hearts in both the normal and diabetic
groups.
Discussion
In the present study, we show that ischemic preconditioning
can protect diabetic rat hearts against ischemia-reperfusion.
Figure 1. Left ventricular developed pressure
in control or preconditioned hearts in response
to sustained ischemia and reperfusion. The
hearts were isolated from normal or diabetic
rats and were either perfused (control) or pre-
conditioned according to the protocol de-
scribed in Methods. The hearts were then sub-
jected to ischemia and reperfusion, and the
LVDP was monitored as described in Methods.
Squares 5 control hearts; circles 5 precondi-
tioned hearts; shaded areas 5 global ischemia.
The interaction between four groups and time
course was significant (p 5 0.0001). **p , 0.01,
***p , 0.001 compared with the control group
(n 5 8).
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Our major findings with the preconditioned hearts are that,
when compared with control hearts, 1) HEP, such as ATP and
CP, was significantly better preserved after ischemia-
reperfusion; 2) the myocardial lactate content was significantly
lower after sustained ischemia; and 3) mitochondrial ATPase
and adenine nucleotide translocase activities were significantly
better preserved after 30 min of reperfusion. In addition, we
have observed for the first time several significant similarities
and differences between normal and diabetic rats: 1) although
the baseline values of LVDP, ATP, CP and mitochondrial
enzyme activities were smaller in diabetic rat hearts, their
recovery rates after ischemia-reperfusion were almost identical
in both normal and diabetic rat hearts; 2) a CP overshoot was
seen immediately after preconditioning in both normal and
diabetic hearts; 3) myocardial damage, estimated by cumula-
tive CK release, was smaller in the preconditioned diabetic
hearts than in the normal hearts; 4) initial glycogen content in
diabetic hearts was significantly greater than in normal hearts;
and 5) although myocardial lactate levels immediately after
sustained ischemia tended to be higher in the control diabetic
hearts than in the control normal hearts, lactate content in the
preconditioned hearts of diabetic rats declined to a similar
extent as that in normal rats. In addition, there were no
significant differences in the LVDP, cumulative CK release,
adenylates and glycogen content between pair weighted rats
(180 to 200 g) and normal rats, suggesting that the difference in
the weight between the normal and diabetic rats was not a
contributing factor in the present study (data not shown).
Mitochondrial function and energy metabolism in precon-
ditioned hearts. It has been proposed that the depression of
mitochondrial ATPase during preconditioning may account for
the reduced rate of ATP consumption and increased cardio-
protection in animals with slow (2,22) as well as fast (23) heart
rates. However, in our previous studies of preconditioned rat
hearts, we observed that ATPase activity was not significantly
depressed either after 5 min of ischemic preconditioning,
30 min of sustained ischemia or 30 min of reperfusion (14).
Moreover, there was no significant difference in either the ATP
Figure 2. Time-dependent as well as cumulative
CK release in the effluent of control and precon-
ditioned rats in response to sustained ischemia
and reperfusion. Coronary effluent was collected,
and CK activity was determined at the indicated
time points for both normal and diabetic rats
according to the protocol described in Methods.
In the time-dependent graphs, the hatched areas
represent global ischemia. Squares 5 control
hearts; circles 5 preconditioned hearts. In the
cumulative CK histograms, solid bars represent
control rats, and hatched bars represent precon-
ditioned rats. The interaction between the four
groups and time course was significant (p 5
0.0001). **p , 0.01, ***p , 0.001 compared with
the control group. †p , 0.05 compared with the
normal preconditioned group (n 5 8).
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content or the decline in the rate of ATP hydrolysis between
the control and preconditioned hearts, suggesting that mito-
chondrial ATPase has only a relatively small effect on ATP
depletion in ischemic rat hearts (14). The fact that the inhibi-
tion of mitochondrial ATPase by oligomycin also has a negli-
gible ATP-sparing effect in the ischemic rat heart is consistent
with our data (24). Thus, there remains some uncertainty
concerning the role of mitochondrial ATPase in maintaining
intracellular ATP content in rats.
It has been reported that diabetic myocardium exhibits a
variety of abnormalities that may contribute to the severity of
the injury associated with ischemia-reperfusion, including a
shift in myosin isozymes from predominantly V1 to V3 (25),
depressed Na1/Ca21 exchange (11), Na1/H1 exchange (26)
and sarcoplasmic reticulum ATPase activities (27), and a
decrease in sensitivity to beta-adrenergic stimulation (28).
Moreover, abnormalities in energy metabolism, glucose trans-
port, as well as decreased phosphofructokinase, glycogen syn-
thetase and pyruvate dehydrogenase activities, have also been
described (12). It seems likely, therefore, that these metabolic
dysfunctions could disrupt the energy balance during ischemic
preconditioning. In the present study, however, we found that
there are many similarities in the recovery rates of HEP,
ATPase and adenine nucleotide translocase activities after
sustained ischemia-reperfusion in both normal and diabetic
rats. These findings suggest that in diabetic rats, as in normal
Figure 3. Myocardial glycogen content in
control and preconditioned hearts. Isolated
hearts from normal and diabetic rats were
subjected to perfusion protocols as de-
scribed in Methods. At preischemic baseline
(baseline), immediately after precondition-
ing (post-IP) and 30 min after sustained
ischemia (post-ische), the hearts were ana-
lyzed for glycogen content (see Methods).
Solid bars 5 control group; hatched bars 5
preconditioned group. **p , 0.01, ***p ,
0.001, §p , 0.001 compared with the group
of normal rats (n 5 8).
Table 2. Energy Level Changes in Control and Preconditioned Hearts in Response to Sustained Ischemia and Reperfusion
Time n ATP ADP AMP CP Cr EC
Normal Rats
Baseline 12 13.8 6 0.15 3.70 6 0.13 0.60 6 0.03 32.5 6 0.32 30.4 6 0.89 0.86 6 0.004
Control group
Ischemia 12 3.72 6 0.16 1.85 6 0.19 10.7 6 0.44 10.5 6 0.30 51.2 6 1.51 0.29 6 0.005
Reperfusion 12 3.40 6 0.10 2.10 6 0.06 1.60 6 0.14 13.4 6 0.73 25.8 6 0.85 0.63 6 0.014
After IP 12 13.3 6 0.21 3.40 6 0.09 0.42 6 0.01 40.1 6 0.50 21.0 6 0.19 0.88 6 0.001
IP group
Ischemia 12 3.54 6 0.11 1.20 6 0.04* 5.34 6 0.16† 7.40 6 0.32 49.6 6 0.98 0.41 6 0.009†
Reperfusion 12 5.91 6 0.23† 2.92 6 0.09* 0.90 6 0.07 29.8 6 1.56† 20.2 6 0.66† 0.76 6 0.010†
Diabetic Rats
Baseline 12 13.9 6 0.43 3.62 6 0.14 1.04 6 0.14 24.2 6 1.01 35.8 6 1.26 0.85 6 0.004
Control group
Ischemia 12 2.89 6 0.10 1.92 6 0.07 10.8 6 0.20 6.50 6 0.49 53.8 6 1.59 0.25 6 0.006
Reperfusion 12 3.02 6 0.11 1.88 6 0.05 1.62 6 0.14 9.62 6 0.43 28.9 6 1.14 0.61 6 0.016
After IP 12 13.2 6 0.88 3.24 6 0.20 0.65 6 0.03 28.6 6 0.90 30.8 6 1.80 0.86 6 0.008
IP group
Ischemia 12 2.68 6 0.11 1.34 6 0.10‡ 6.68 6 0.20† 5.18 6 0.32 51.3 6 2.16 0.31 6 0.008†
Reperfusion 12 5.68 6 0.24† 2.02 6 0.07 0.88 6 0.04* 21.8 6 0.54† 22.6 6 1.26 0.78 6 0.006†
*p , 0.01, †p , 0.001, ‡p , 0.05 compared with the control group (n 5 12). Isolated hearts from normal or diabetic rats were subjected to ischemic preconditioning
(IP) or simple perfusion (Control) protocols, followed by sustained ischemia and reperfusion, as described in Methods, and the values of adenosine triphosphate (ATP),
adenosine diphosphate (ADP), adenosine monophosphate (AMP), creatine phosphate (CP), creatine (Cr) and energy charge (EC) were determined. Initial values are
compared with those obtained immediately after ischemic preconditioning in the preconditioned group and immediately after sustained ischemia (Ischemia) or 30 min
of reperfusion (Reperfusion) for all groups. Data are presented as mean value 6 SEM (mmol/g dry weight).
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rats, mitochondrial ATPase activity may contribute to the
restoration of HEP.
We observed that adenine nucleotide translocase activity
recovered significantly in the preconditioned groups of both
normal and diabetic rats at 30 min after reperfusion, when
compared with the control groups. Previous studies have
suggested that myocardial ischemia results in a significant
depression in translocase activity (29), and that its activity and
oxidative phosphorylation are closely related to contractile
recovery after ischemia-reperfusion (20). Because alterations
in carnitine level have been reported in diabetic myocardium
(30), it seems possible that translocase activity may be affected
in this tissue. Our present data, however, suggest that the
preservation of translocase may contribute to the restoration
of HEP and myocardial contractile function in the precondi-
tioned diabetic as well as normal rat hearts. In addition, there
was no significant difference in isolated mitochondrial protein
among the four groups, although we did not determine the
proportion of dead, inert or active mitochondria.
Cardioprotective efficiency of preconditioning in diabetic
hearts. Our present data show that the cumulative CK release
was significantly lower in the preconditioned group of diabetic
hearts than in the normal hearts, although there was no
significant difference in CK release in the control groups
between both rats. Presently there are conflicting opinions
concerning the tolerance of diabetic hearts to ischemic injury
(31–33). The present results suggest that under our experimen-
tal conditions there is no difference in myocardial sensitivity to
ischemia-reperfusion injury between the control groups of
normal and diabetic rats, and that the cardioprotective effi-
ciency of preconditioning is potentiated in diabetic rats.
It is well known that intracellular acidosis during ischemia is
one of the most important factors affecting the extent of
myocardial damage after reperfusion. In the present study,
although lactate levels during sustained ischemia tended to be
higher in the control group of diabetic hearts than in control
normal hearts, its production in preconditioned hearts was
inhibited to a similar extent in both diabetic and normal rats,
suggesting a lower lactate production rate in these hearts
during ischemia. Because glucose transport and phosphofruc-
tokinase are inhibited in diabetic hearts, it can be expected that
lactate production would be lower in ischemic diabetic hearts.
However, our data show that lactate production was not
inhibited in the control group of diabetic rats. Our data are
therefore in agreement with those of Tani and Neely (34), who
have reported that lactate production was not inhibited at the
end of ischemia in perfused diabetic rat hearts. However, the
contradictory data of Khandoudi et al. (35) suggest that this
issue is not yet resolved.
The possible contribution of stored glycogen is of interest
here. In the present study, glycogen content in diabetic hearts
was significantly greater than that in normal hearts. It is
noteworthy that the difference in glycogen content between
baseline levels and those after sustained ischemia was larger in
the control group of diabetic rats than in normal rats, suggest-
Figure 4. Myocardial lactate content in control and preconditioned
hearts. Isolated hearts from normal and diabetic rats were subjected to
perfusion protocols as described in Methods. At the end of sustained
ischemia, the hearts were homogenized and analyzed for lactate
content (see Methods). Solid bars represent the control group;
hatched bars represent the preconditioned group. ***p , 0.001 (n 5
8).
Figure 5. Mitochondrial enzyme activ-
ity. Control and preconditioned hearts
were subjected to sustained ischemia
and reperfusion, the mitochondria
were isolated, and enzyme activity was
assayed as described in Methods. The
values for NADH cytochrome c oxi-
doreductase, ATPase and adenine nu-
cleotide translocase were determined
after 30 min of reperfusion and are
expressed as a percent of preischemic
values (see text) for both normal and
diabetic rats. Solid bars 5 control
group; hatched bars 5 preconditioned
group. *p , 0.05, ***p , 0.001 (n 5
8).
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ing that glycolytic metabolites were produced in greater quan-
tities in diabetic hearts under ischemic conditions. Neely and
Morgan (12) also reported higher levels of glycogen in diabetic
myocardium, suggesting that higher levels of lactate may
accumulate in these hearts during ischemia. After precondi-
tioning, myocardial glycogen content was markedly reduced in
diabetic hearts, and the production of glycolytic metabolites
during the sustained ischemia was inhibited to a similar extent
as that in normal hearts, as indicated by the lactate content.
Therefore, it seems reasonable to speculate that, in diabetic
hearts, preconditioning may induce a more efficient depletion
of myocardial glycogen content, thereby contributing to a
lower lactate production during sustained ischemia.
The present data also suggest that intracellular acidosis
during ischemia may be attenuated in the preconditioned
hearts, because it has been reported that anaerobic glycolysis is
the major source of H1 production during myocardial isch-
emia (36), and that lactate production by glycolysis closely
correlates with intracellular acidosis (37). Recently, Wolfe et
al. (38) reported that glycogen depletion and the concomitant
attenuation of intracellular acidosis during ischemia appear to
be an important mechanism for cardioprotection in ischemic
preconditioned rat hearts. Albuquerque et al. (39) have also
reported that lowering of intracellular pH results in decreased
HEP content and increased deleterious myocardial dysfunc-
tion. Although we did not measure intracellular pH, it appears
reasonable to propose that similar effects would have been
observed in our model. Taking all these factors into consider-
ation, a greater depression of lactate production in the pre-
conditioned diabetic heart may contribute to the attenuation of
intracellular acidosis and may result in more efficient cardio-
protection.
There are presently conflicting data with regard to the effect
of ischemic preconditioning on diabetic hearts. Liu et al. (40)
have demonstrated that preconditioning can significantly re-
duce the infarct size in the non–insulin-dependent diabetic rat
hearts. In contrast, Tosaki et al. (41) have reported that
preconditioning does not afford similar protection in
streptozocin-induced diabetic rat hearts. Although our results
suggest the possibility that preconditioning provides greater
protection in isolated diabetic rat hearts, further studies will be
required to resolve this issue.
Conclusions. We demonstrate in this study that in both
normal and diabetic rats, the preservation of mitochondrial
ATPase and adenine nucleotide translocase activities can
contribute to the restoration of HEP after sustained ischemia-
reperfusion in the ischemic preconditioned heart. Our data
show an inhibition of glycolysis during ischemia in precondi-
tioned hearts and suggest, therefore, that the attenuation of
intracellular acidosis may be important for cardioprotection in
the preconditioned heart. Moreover, we show that in the
diabetic myocardium, preconditioning may offer greater pro-
tection than in normal myocardium, as illustrated by the lower
cumulative CK release.
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